Menu

Tuberculosis & Transplantation - Diagnosis & Management of Donor-Derived Infection

  • View
  • Repeats
    • Printer-friendly version

    presented by

    Michele I. Morris, M.D.

    Associate Professor of Clinical Medicine, Division of Infectious Diseases

    University of Miami Miller School of Medicine

     

    moderated by

    David Ashkin, MD  

    Medical Director, Southeastern National Tuberculosis Center

     

     

     

    OVERVIEW

     

    This presentation will include an overview of the organ procurement process and the current donor screening techniques. It will outline the current status of tuberculosis in transplantation and review the historical experience with donor-derived tuberculosis. Diagnosis and management of donor-derived tuberculosis will be covered.

     

     

     

    Upon completion of this course, the participant will be able to:

     

    • Describe the solid organ donor infection screening process
    • Discuss the challenges of preventing donor-derived tuberculosis
    • Understand the management of solid organ recipients at risk for donor-derived tuberculosis

     

     

     

    TARGET AUDIENCE

     

    The event is designed for physicians, nurses, pharmacists, and field staff who are interested in a multidisciplinary and global approach toward the care and management of the patient infected with tuberculosis.

     

     

     

    REGISTRATION

     

    • This is a free event, open to all regions. However, pre-registration is required.  
    • To register, go to http://sntc.medicine.ufl.edu/training.aspx
    • Registration closes on Monday, March 18th, 2013.
    • Online Webinar: Listen to the lecture and view the presenter's slides on your computer and online via AdobeConnect. Ask questions and participate using the discussion tool. Connection information will be provided by email several days before the event and posted on our home page (http://sntc.medicine.ufl.edu) under What's Happening.

     

     

     

    CONTINUING EDUCATION

     

    Continuing education credits have been applied for.

     

     

     

    CONTINUING EDUCATION FACULTY DISCLOSURE

     

    Dr. Morris may discuss the off label use of rifampin for treatment of latent TB as well as quinolone use as an alternative therapy.  

     

     

     

    UNABLE TO ATTEND? 

     

    This event will be recorded and posted on our Archived Webinars page 1-2 weeks post event.

     

     

     

    QUESTIONS

     

    Contact Kristina Ottenwess at the Southeastern National Tuberculosis Center by email at kristina.ottenwess@medicine.ufl.edu or call 352-273-7682 or toll free at 888-265-SNTC (7682).

    Timezone: 
    EST
    Tags:
    Contact Us